NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

This is true. From the 10Q:

The trial is on partial clinical hold for screening of new patients for further enrollment; however, over 300 of the planned 348 patients are enrolled in the trial, and the patients already in the trial have continued to be treated in accordance with the trial protocol, without interruption. The Company is in ongoing dialog with regulators in regard to the partial hold.